Ftse Mib
34.249,77
0,91%
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
NASDAQ Composite
15.927,90
2,03%
Bitcoin
63.181,00
-0,88%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistenza
Home Investire Azioni U.S.A. NASDAQ Sana Biotechnology Inc (SANA) Sana Biotechnology Inc (SANA) Notizie

Sana Biotechnology Inc

SANA
8,72
0,22 (2,59%)
27 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
08/3/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202422:12EDGAR2Form 8-K - Current report
29/2/202422:05GLOBESana Biotechnology Reports Fourth Quarter and Full Year 2023..
28/2/202422:05GLOBESana Biotechnology to Present at the Cowen 44th Annual..
14/2/202422:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/2/202422:05GLOBESana Biotechnology Announces Publication of Preclinical..
12/2/202422:05GLOBESana Biotechnology Announces Closing of Upsized Public..
08/2/202423:20EDGAR2Form 8-K - Current report
08/2/202422:49EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08/2/202407:22GLOBESana Biotechnology Announces Pricing of Upsized Public..
08/2/202403:59EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
07/2/202423:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
07/2/202422:12EDGAR2Form 8-K - Current report
07/2/202422:01GLOBESana Biotechnology Announces Proposed Public Offering of..
09/1/202415:00EDGAR2Form 8-K - Current report
05/1/202415:00GLOBESana Biotechnology Announces FDA Clearance of..
03/1/202422:05GLOBESana Biotechnology to Present at the 42nd Annual J.P. Morgan..
18/12/202322:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202322:34EDGAR2Form 144 - Report of proposed sale of securities
11/12/202322:01EDGAR2Form 8-K - Current report
11/12/202315:00GLOBESana Biotechnology Highlights Preclinical Data Supporting..
01/12/202322:05GLOBESana Biotechnology Publishes Early Clinical Data Showing..
28/11/202301:01PRNUSFlagship Pioneering Marks Official Opening of UK Hub with..
21/11/202315:00GLOBESana Biotechnology to Present at November and December 2023..
21/11/202312:00PRNUSFlagship Pioneering Unveils Quotient Therapeutics to Create..
17/11/202315:00GLOBEUppsala University Hospital and Sana Biotechnology Announce..
09/11/202322:05GLOBESana Biotechnology Announces FDA Clearance of..
08/11/202322:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202322:14EDGAR2Form 8-K - Current report
08/11/202322:05GLOBESana Biotechnology Reports Third Quarter 2023 Financial..
03/11/202321:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202321:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202314:05GLOBESana Biotechnology Announces Five Presentations at the 65th..
01/11/202315:30PRNUSFlagship Pioneering Launches Pioneering Intelligence
10/10/202322:21EDGAR2Form 8-K - Current report
10/10/202322:15GLOBESana Biotechnology Announces Increased Focus on..
13/9/202312:04EDGAR2Form 8-K - Current report
11/9/202312:30PRNUSFlagship Pioneering Announces Appointment of Amanda Kay as..
30/8/202322:05GLOBESana Biotechnology to Present at September 2023 Investor..
29/8/202315:00PRNUSInvaio achieves first registration for citrus greening..
21/8/202322:05EDGAR2Form 8-K - Current report
03/8/202322:23EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202322:14EDGAR2Form 8-K - Current report
03/8/202322:05GLOBESana Biotechnology Reports Second Quarter 2023 Financial..
16/6/202315:00GLOBESana Biotechnology Highlights Preclinical Data from..
31/5/202322:05GLOBESana Biotechnology to Present at June 2023 Investor..
16/5/202312:00PRNUSFlagship Pioneering Launches Metaphore Biotechnologies to..
08/5/202322:35GLOBESana Biotechnology Announces Preclinical Data Published in..
08/5/202322:05GLOBESana Biotechnology Reports First Quarter 2023 Financial..
Apertura: 8,57 Min: 8,46 Max: 8,88
Chiusura: 8,50

La tua Cronologia

NASDAQ
SANA
Sana Biotechnology
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network